{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:37:56Z","timestamp":1792791476757,"version":"4.5.0"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T00:00:00Z","timestamp":1792540800000},"content-version":"vor","delay-in-days":20,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"NHMRC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","heartrhythmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart Rhythm"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.hrthm.2026.10.039","type":"journal-article","created":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T16:04:15Z","timestamp":1792685055000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["CATHETER ABLATION VERSUS SHAM FOR SYMPTOMATIC ATRIAL FIBRILLATION: A SYSTEMATIC REVIEW AND BAYESIAN META-ANALYSIS OF RANDOMIZED TRIALS"],"prefix":"10.1016","author":[{"given":"Saikiran","family":"Kakarla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidehiro","family":"Iwakawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason G.","family":"Andrade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan P.","family":"Ariyaratnam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie A.","family":"Gunawardene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nassir","family":"Marrouche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa E.","family":"Middeldorp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian D.","family":"Elliott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter M.","family":"Kistler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan M.","family":"Kalman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3803-8429","authenticated-orcid":false,"given":"Prashanthan","family":"Sanders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"13","key":"10.1016\/j.hrthm.2026.10.039_bib1","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1001\/jama.2019.0693","article-title":"Effect of Catheter Ablation vs Antiarrhythmic Drug Therapy on Mortality, Stroke, Bleeding, and Cardiac Arrest Among Patients With Atrial Fibrillation: The CABANA Randomized Clinical Trial","volume":"321","author":"Packer","year":"2019","journal-title":"JAMA"},{"issue":"13","key":"10.1016\/j.hrthm.2026.10.039_bib2","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1001\/jama.2019.0692","article-title":"Effect of Catheter Ablation vs Medical Therapy on Quality of Life Among Patients With Atrial Fibrillation: The CABANA Randomized Clinical Trial","volume":"321","author":"Mark","year":"2019","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.hrthm.2026.10.039_bib3","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1001\/jama.2019.0335","article-title":"Effect of Catheter Ablation vs Antiarrhythmic Medication on Quality of Life in Patients With Atrial Fibrillation: The CAPTAF Randomized Clinical Trial","volume":"321","author":"Blomstr\u00f6m-Lundqvist","year":"2019","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.hrthm.2026.10.039_bib4","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1056\/NEJMoa2029554","article-title":"Cryoballoon Ablation as Initial Therapy for Atrial Fibrillation","volume":"384","author":"Wazni","year":"2021","journal-title":"New England Journal of Medicine"},{"issue":"2","key":"10.1016\/j.hrthm.2026.10.039_bib5","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1056\/NEJMoa2212540","article-title":"Progression of Atrial Fibrillation after Cryoablation or Drug Therapy","volume":"388","author":"Andrade","year":"2023","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.hrthm.2026.10.039_bib6","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1093\/eurheartj\/ehac692","article-title":"Healthcare utilization and quality of life for atrial fibrillation burden: the CIRCA-DOSE study","volume":"44","author":"Andrade","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2026.10.039_bib7","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.g3253","article-title":"Use of placebo controls in the evaluation of surgery: systematic review","volume":"348","author":"Wartolowska","year":"2014","journal-title":"BMJ"},{"issue":"15","key":"10.1016\/j.hrthm.2026.10.039_bib8","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1056\/NEJMoa1402670","article-title":"A Controlled Trial of Renal Denervation for Resistant Hypertension","volume":"370","author":"Bhatt","year":"2014","journal-title":"New England Journal of Medicine"},{"issue":"10115","key":"10.1016\/j.hrthm.2026.10.039_bib9","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(17)32714-9","article-title":"Percutaneous coronary intervention in stable angina (ORBITA): a double-blind, randomised controlled trial","volume":"391","author":"Al-Lamee","year":"2018","journal-title":"The Lancet"},{"issue":"25","key":"10.1016\/j.hrthm.2026.10.039_bib10","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1056\/NEJMoa2310610","article-title":"A Placebo-Controlled Trial of Percutaneous Coronary Intervention for Stable Angina","volume":"389","author":"Rajkumar","year":"2023","journal-title":"New England Journal of Medicine"},{"issue":"5","key":"10.1016\/j.hrthm.2026.10.039_bib11","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1161\/HYPERTENSIONAHA.123.22251","article-title":"Impact of Antihypertensive Medication Changes After Renal Denervation Among Different Patient Groups: SPYRAL HTN-ON MED","volume":"81","author":"Townsend","year":"2024","journal-title":"Hypertension"},{"issue":"0","key":"10.1016\/j.hrthm.2026.10.039_bib12","article-title":"Why Sham Studies Are a Sham in 2026! Sham-controlled AF ablation trials as a case study","volume":"0","author":"Lakkireddy","year":"2026","journal-title":"Heart Rhythm"},{"issue":"0","key":"10.1016\/j.hrthm.2026.10.039_bib13","article-title":"The Indispensable Role of Sham Controls in Evaluating Interventional Therapies: The Need for Objective Rigor in Atrial Fibrillation Ablation","volume":"0","author":"Bunch","year":"2026","journal-title":"Heart Rhythm"},{"issue":"14","key":"10.1016\/j.hrthm.2026.10.039_bib14","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1001\/jama.2024.17921","article-title":"Pulmonary Vein Isolation vs Sham Intervention in Symptomatic Atrial Fibrillation: The SHAM-PVI Randomized Clinical Trial","volume":"332","author":"Dulai","year":"2024","journal-title":"JAMA"},{"issue":"25","key":"10.1016\/j.hrthm.2026.10.039_bib15","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1161\/CIRCULATIONAHA.126.079484","article-title":"Pulsed Field Ablation Versus Sham to Treat Atrial Fibrillation: The PFA-SHAM Randomized Clinical Trial","volume":"153","author":"Osmancik","year":"2026","journal-title":"Circulation"},{"issue":"0","key":"10.1016\/j.hrthm.2026.10.039_bib16","article-title":"Catheter ablation for symptomatic atrial fibrillation (PVI-SHAM-AF): a randomised, double-blind, sham-controlled, multicentre trial","volume":"0","author":"Wachter","year":"2026","journal-title":"The Lancet"},{"issue":"2","key":"10.1016\/j.hrthm.2026.10.039_bib17","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.ahj.2013.04.015","article-title":"Interpreting changes in quality of life in atrial fibrillation: How much change is meaningful?","volume":"166","author":"Dorian","year":"2013","journal-title":"American Heart Journal"},{"issue":"5","key":"10.1016\/j.hrthm.2026.10.039_bib18","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.118.005358","article-title":"Defining Clinically Important Difference in the Atrial Fibrillation Effect on Quality-of-Life Score","volume":"12","author":"Holmes","year":"2019","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.hrthm.2026.10.039_bib19","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.l6890","article-title":"Synthesis without meta-analysis (SWiM) in systematic reviews: reporting guideline","author":"Campbell","year":"2020","journal-title":"BMJ"},{"issue":"10","key":"10.1016\/j.hrthm.2026.10.039_bib20","doi-asserted-by":"crossref","first-page":"e2634","DOI":"10.1016\/j.hrthm.2026.05.002","article-title":"Why electrophysiologists need Bayesian thinking, or \u2026 what are the chances, doctor?","volume":"23","author":"Oliveira","year":"2026","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2026.10.039_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v093.i06","article-title":"Bayesian Random-Effects Meta-Analysis Using the bayesmeta R Package","volume":"93","author":"R\u00f6ver","year":"2020","journal-title":"Journal of Statistical Software"},{"issue":"1","key":"10.1016\/j.hrthm.2026.10.039_bib22","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1467-985X.2008.00552.x","article-title":"A re-evaluation of random-effects meta-analysis","volume":"172","author":"Higgins","year":"2009","journal-title":"J R Stat Soc Ser A Stat Soc"},{"issue":"1","key":"10.1016\/j.hrthm.2026.10.039_bib23","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/jrsm.1217","article-title":"Meta-analysis of few small studies in orphan diseases","volume":"8","author":"Friede","year":"2017","journal-title":"Res Synth Methods"},{"issue":"3","key":"10.1016\/j.hrthm.2026.10.039_bib24","doi-asserted-by":"crossref","first-page":"357","DOI":"10.2307\/2983527","article-title":"Bayesian Approaches to Randomized Trials","volume":"157","author":"Spiegelhalter","year":"1994","journal-title":"J R Stat Soc Ser A Stat Soc"},{"issue":"10","key":"10.1016\/j.hrthm.2026.10.039_bib25","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1002\/clc.24092","article-title":"Short\u2010term and long\u2010term effects of cryoballoon ablation versus antiarrhythmic drug therapy as first\u2010line treatment for paroxysmal atrial fibrillation: A systematic review and meta\u2010analysis","volume":"46","author":"Liu","year":"2023","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.hrthm.2026.10.039_bib26","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.jclinepi.2022.07.014","article-title":"GRADE Guidance 34: update on rating imprecision using a minimally contextualized approach","volume":"150","author":"Zeng","year":"2022","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.hrthm.2026.10.039_bib27","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ahj.2023.12.007","article-title":"Feasibility of double-blinded, placebo-controlled interventional study for assessing catheter ablation efficacy in persistent atrial fibrillation: Insights from the ORBITA AF feasibility study","volume":"269","author":"Kanthasamy","year":"2024","journal-title":"Am Heart J"},{"issue":"1","key":"10.1016\/j.hrthm.2026.10.039_bib28","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0167-5273(01)00522-8","article-title":"Electrical cardioversion for atrial fibrillation: outcomes in \u2018real-life\u2019 clinical practice","volume":"81","author":"Berry","year":"2001","journal-title":"International Journal of Cardiology"},{"issue":"1","key":"10.1016\/j.hrthm.2026.10.039_bib29","first-page":"85","article-title":"The Association Between Atrial Fibrillation Burden and Quality of Life","volume":"12","author":"Dulai","year":"2026","journal-title":"JACC: Clinical Electrophysiology"},{"issue":"9","key":"10.1016\/j.hrthm.2026.10.039_bib30","first-page":"1983","article-title":"Sustained Improvement in Quality of Life Following Catheter Ablation for Persistent AF Beyond 3 Years","volume":"11","author":"William","year":"2025","journal-title":"JACC: Clinical Electrophysiology"},{"issue":"11","key":"10.1016\/j.hrthm.2026.10.039_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1001\/jamacardio.2021.3063","article-title":"Association of Atrial Fibrillation Burden With Health-Related Quality of Life After Atrial Fibrillation Ablation","volume":"6","author":"Samuel","year":"2021","journal-title":"JAMA Cardiol"},{"issue":"29","key":"10.1016\/j.hrthm.2026.10.039_bib32","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1093\/eurheartj\/ehae291","article-title":"Catheter ablation for persistent atrial fibrillation: patterns of recurrence and impact on quality of life and health care utilization","volume":"45","author":"Crowley","year":"2024","journal-title":"European Heart Journal"}],"container-title":["Heart Rhythm"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547527126029036?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547527126029036?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:43:25Z","timestamp":1792788205000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1547527126029036"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":32,"alternative-id":["S1547527126029036"],"URL":"https:\/\/doi.org\/10.1016\/j.hrthm.2026.10.039","relation":{},"ISSN":["1547-5271"],"issn-type":[{"value":"1547-5271","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CATHETER ABLATION VERSUS SHAM FOR SYMPTOMATIC ATRIAL FIBRILLATION: A SYSTEMATIC REVIEW AND BAYESIAN META-ANALYSIS OF RANDOMIZED TRIALS","name":"articletitle","label":"Article Title"},{"value":"Heart Rhythm","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hrthm.2026.10.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc. on behalf of Heart Rhythm Society.","name":"copyright","label":"Copyright"}]}}